New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2012-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.00944.2011PMID 22245772PMCID PMC3330808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.

  2012cited by this paper
• Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodeling.

  2011cited by this paper
• Role of Reactive Oxygen Species and Redox in Regulating the Function of Transient Receptor Potential Channels

  2011cited by this paper
• Role for miR-204 in human pulmonary arterial hypertension

  2011cited by this paper
• STIM2 contributes to enhanced store-operated Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension

  2011cited by this paper
• The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.

  2011cited by this paper
• Ins(1,4,5)P3 interacts with PIP2 to regulate activation of TRPC6/C7 channels by diacylglycerol in native vascular myocytes

  2010cited by this paper
• Intracellular Ca2+ Silences L-Type Ca2+ Channels in Mesenteric Veins: Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers

  2010cited by this paper
• Activation of L-type Ca2+ channels by protein kinase C is reduced in smooth muscle-specific Na+/Ca2+ exchanger knockout mice.

  2010cited by this paper
• The contribution of TRPC1 and STIM1 to capacitative Ca(2+) entry in pulmonary artery.

  2010influential reference
• Idiopathic pulmonary arterial hypertension

  2010cited by this paper
• Introduction to TRP channels: structure, function, and regulation.

  2010cited by this paper
• Reverse mode Na+/Ca2+ exchange mediated by STIM1 contributes to Ca2+ influx in airway smooth muscle following agonist stimulation

  2010cited by this paper
• Knockout of Na+/Ca2+ exchanger in smooth muscle attenuates vasoconstriction and L-type Ca2+ channel current and lowers blood pressure.

  2010cited by this paper
• KCNQ potassium channels: new targets for pulmonary vasodilator drugs?

  2010cited by this paper
• Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

  2010cited by this paper
• Intricate interaction between store-operated calcium entry and calcium-activated chloride channels in pulmonary artery smooth muscle cells.

  2010cited by this paper
• Intracellular Ca 2 (cid:1) Silences L-Type Ca 2 (cid:1) Channels in Mesenteric Veins Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers

  2010cited by this paper
• The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension.

  2010influential reference
• Orai1 interacts with STIM1 and mediates capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells.

  2010cited by this paper
• Diagnosis and assessment of pulmonary arterial hypertension

  2010cited by this paper
• TRPC1 and STIM1 mediate capacitative Ca2+ entry in mouse pulmonary arterial smooth muscle cells

  2009influential reference
• Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration.

  2009cited by this paper
• Diagnosis and assessment of pulmonary arterial hypertension.

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Caveolin-1 scaffold domain interacts with TRPC1 and IP3R3 to regulate Ca2+ store release-induced Ca2+ entry in endothelial cells.

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Capacitative calcium entry: from concept to molecules

  2009cited by this paper
• Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-β/NFAT Axis

  2009cited by this paper
• Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells

  2009cited by this paper
• Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

  2009cited by this paper
• Phosphorylation alters the pharmacology of Ca2+‐activated Cl‐ channels in rabbit pulmonary arterial smooth muscle cells

  2009cited by this paper
• Regulation of store-operated Ca2+ entry in pulmonary artery smooth muscle cells.

  2009cited by this paper
• KCNQ Modulators Reveal a Key Role for KCNQ Potassium Channels in Regulating the Tone of Rat Pulmonary Artery Smooth Muscle

  2009cited by this paper
• Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem.

  2009cited by this paper
• Cellular and molecular basis of pulmonary arterial hypertension.

  2009cited by this paper
• STIMulating store-operated Ca2+ entry

  2009influential reference
• A Functional Single-Nucleotide Polymorphism in the TRPC6 Gene Promoter Associated With Idiopathic Pulmonary Arterial Hypertension

  2009cited by this paper
• The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers

  2008cited by this paper
• REGULATION OF PULMONARY VASOCONSTRICTION BY AGONISTS AND CAVEOLAE

  2008influential reference
• Upregulation of Na /Ca exchanger contributes to the enhanced Ca entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension

  2007cited by this paper
• Molecular basis of the CRAC channel.

  2007cited by this paper
• Calcium transporters and signalling in smooth muscles.

  2007cited by this paper
• Pathology of pulmonary hypertension.

  2007cited by this paper
• ATP promotes NCX-reversal in aortic smooth muscle cells by DAG-activated Na+ entry.

  2007cited by this paper
• Na+ entry via TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cells.

  2007cited by this paper
• Increased smooth muscle cell expression of caveolin‐1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension

  2007cited by this paper
• [Animal models of pulmonary arterial hypertension].

  2007cited by this paper
• Upregulation of Na+/Ca2+ exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.

  2007influential reference
• Role of the adventitia in pulmonary vascular remodeling.

  2006cited by this paper
• Mechanism of the Inhibition of Ca2+-Activated Cl− Currents by Phosphorylation in Pulmonary Arterial Smooth Muscle Cells

  2006cited by this paper
• Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange

  2006cited by this paper
• T-type Ca2+ channels in vascular smooth muscle: multiple functions.

  2006cited by this paper
• Key Role of Kv1 Channels in Vasoregulation

  2006cited by this paper
• Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.

  2006cited by this paper
• EVOLUTION AND OUTCOMES OF A RAPID RESPONSE TEAM

  2006cited by this paper
• Mechanism of the Inhibition of Ca 2 +-Activated Cl − Currents by Phosphorylation in Pulmonary Arterial Smooth Muscle Cells

  2006cited by this paper
• Permeation and selectivity of TRP channels.

  2006cited by this paper
• Caveolin-1 Regulates Store-Operated Ca2+ Influx by Binding of Its Scaffolding Domain to Transient Receptor Potential Channel-1 in Endothelial Cells

  2006cited by this paper
• Pulmonary arterial hypertension in France: results from a national registry.

  2006cited by this paper
• Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai

  2006cited by this paper
• STIM1, an essential and conserved component of store-operated Ca2+ channel function

  2005cited by this paper
• Pathogenesis of pulmonary arterial hypertension: the need for multiple hits.

  2005cited by this paper
• Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

  2005cited by this paper
• STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane

  2005cited by this paper
• Role of Na/Ca 2 exchange in regulating cytosolic Ca 2 in cultured human pulmonary artery smooth muscle cells

  2005cited by this paper
• Heteromultimeric Kv1 Channels Contribute to Myogenic Control of Arterial Diameter

  2005cited by this paper
• Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells.

  2005influential reference
• Calcium Signaling in Cardiac Ventricular Myocytes

  2005cited by this paper
• Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.

  2004cited by this paper
• Chronic Hypoxia–Induced Upregulation of Store-Operated and Receptor-Operated Ca2 Channels in Pulmonary Arterial Smooth Muscle Cells: A Novel Mechanism of Hypoxic Pulmonary Hypertension

  2004influential reference
• Targeted Ablation of Plasma Membrane Ca2+-ATPase (PMCA) 1 and 4 Indicates a Major Housekeeping Function for PMCA1 and a Critical Role in Hyperactivated Sperm Motility and Male Fertility for PMCA4*

  2004cited by this paper
• Overexpression of TRPC 1 enhances pulmonary vasoconstriction induced by capacitative Ca 2 entry

  2004cited by this paper
• Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle

  2004cited by this paper
• Preferential Expression and Function of Voltage-Gated, O2-Sensitive K+ Channels in Resistance Pulmonary Arteries Explains Regional Heterogeneity in Hypoxic Pulmonary Vasoconstriction: Ionic Diversity in Smooth Muscle Cells

  2004cited by this paper
• Disruption of Endothelial-Cell Caveolin-1&agr;/Raft Scaffolding During Development of Monocrotaline-Induced Pulmonary Hypertension

  2004cited by this paper
• Overexpression of human KCNA5 increases IK V and enhances apoptosis.

  2004cited by this paper
• Ca(2+) signaling by TRPC3 involves Na(+) entry and local coupling to the Na(+)/Ca(2+) exchanger.

  2004cited by this paper
• Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

  2004cited by this paper
• Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

  2004cited by this paper
• Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry.

  2004influential reference
• Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

  2004cited by this paper
• Ca2+ Signaling by TRPC3 Involves Na+ Entry and Local Coupling to the Na+/Ca2+ Exchanger*

  2004cited by this paper
• Hypoxic Pulmonary Vasoconstriction: Heterogeneity

  2004cited by this paper
• In Vivo Gene Transfer of the O2-Sensitive Potassium Channel Kv1.5 Reduces Pulmonary Hypertension and Restores Hypoxic Pulmonary Vasoconstriction in Chronically Hypoxic Rats

  2003cited by this paper
• TRPC1 store-operated cationic channel subunit.

  2003influential reference
• Calcium signalling: dynamics, homeostasis and remodelling

  2003cited by this paper
• Regulation of cell cycle progression by calcium/calmodulin-dependent pathways.

  2003cited by this paper
• PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression.

  2003influential reference
• Caveolin-1 Contributes to Assembly of Store-operated Ca2+ Influx Channels by Regulating Plasma Membrane Localization of TRPC1*

  2003influential reference
• Primary pulmonary hypertension.

  2003cited by this paper
• TRP channels as cellular sensors

  2003cited by this paper
• Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells.

  2003cited by this paper
• Nitric oxide induces apoptosis by activating K+ channels in pulmonary vascular smooth muscle cells.

  2002cited by this paper
• Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels

  2002cited by this paper
• Calcium signalling and control of cell proliferation by tyrosine kinase receptors (review).

  2002cited by this paper
• Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice

  2002cited by this paper
• Caveolae: From Cell Biology to Animal Physiology

  2002cited by this paper
• Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation.

  2002cited by this paper
• Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes.

  2001cited by this paper

• Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension

  2025cites this paper
• Targeting PDGFR, EGFR, FGFR, and VEGFR: Key Receptor Tyrosine Kinases‐Driven Metabolic Reprogramming in Pulmonary Arterial Hypertension

  2025cites this paper
• Piezo1 in heart failure: A new perspective from cytomechanical sensing to diverse cellular pathways

  2025cites this paper
• Growth factors involved in vascular remodeling in pulmonary arterial hypertension

  2025cites this paper
• Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease

  2025cites this paper
• MicroRNA-210-5p - a New Druggable Target for Pulmonary Hypertension?

  2025cites this paper
• Is Inducible Nitric Oxide Synthase (iNOS) Promising as a New Target Against Pulmonary Hypertension?

  2025cites this paper
• Imaging Ca2+ Signals in Small Pulmonary Veins at Physiological Intraluminal Pressures

  2025cites this paper
• Celastrol has beneficial effects on pulmonary hypertension associated with bronchopulmonary dysplasia: Preclinical study outcomes.

  2025cites this paper
• Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension

  2024cites this paper
• Salidroside ameliorates hypoxic pulmonary hypertension by regulating the two-pore domain potassium TASK-1 channel.

  2024cites this paper
• A comprehensive analysis of genes associated with hypoxia and cuproptosis in pulmonary arterial hypertension using machine learning methods and immune infiltration analysis: AHR is a key gene in the cuproptosis process

  2024cites this paper
• Unraveling the pathogenesis of viral-induced pulmonary arterial hypertension: Possible new therapeutic avenues with mesenchymal stromal cells and their derivatives.

  2024cites this paper
• Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis

  2024cites this paper
• Impact and mechanisms of drag-reducing polymers on shear stress regulation in pulmonary hypertension

  2024cites this paper
• Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials.

  2024cites this paper
• Up-regulated expression of two-pore domain K+ channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension

  2024influential citation
• Calcium sensing receptor: A promising therapeutic target in pulmonary hypertension.

  2024cites this paper
• Osteopontin in Pulmonary Hypertension

  2023cites this paper
• Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension

  2023cites this paper
• The Anti-Inflammatory Effects and Clinical Potential of Dexmedetomidine in Pulmonary Arterial Hypertension

  2023cites this paper
• Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target

  2022cites this paper
• Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach

  2022cites this paper
• Corosolic acid ameliorates vascular remodeling in pulmonary arterial hypertension via the downregulation of STAT3 signaling.

  2022cites this paper
• Pathophysiology and Pathogenic Mechanisms of Pulmonary Hypertension: Role of Membrane Receptors, Ion Channels and Ca2+ Signaling.

  2022cites this paper
• Translational Potential of Targeting Anoctamin-1-Encoded Calcium-Activated Chloride Channels in Hypertension.

  2022cites this paper
• A topological data analysis study on murine pulmonary arterial trees with pulmonary hypertension.

  2022cites this paper
• Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report

  2022cites this paper
• Upregulated ClC3 channels/transporters elicit swelling-activated Cl- currents and induce excessive cell proliferation in idiopathic pulmonary arterial hypertension.

  2022cites this paper
• Cinaciguat (BAY-582667) Modifies Cardiopulmonary and Systemic Circulation in Chronically Hypoxic and Pulmonary Hypertensive Neonatal Lambs in the Alto Andino

  2022cites this paper
• The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure

  2022cites this paper
• SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells.

  2022cites this paper
• CONTRIBUTION OF STIM-ACTIVATED TRPC-ORAI CHANNELS IN PULMONARY HYPERTENSION INDUCED BY CHRONIC SUSTAINED AND INTERMITTENT HYPOXIA.

  2022cites this paper
• Crucial Role of Stromal Interaction Molecule-Activated TRPC-ORAI Channels in Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia

  2022cites this paper
• Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway

  2022cites this paper
• LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca2+]i in Pulmonary Arterial Smooth Muscle Cells.

  2022cites this paper
• Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

  2022cites this paper
• Targeting JP2: A New Treatment for Pulmonary Hypertension

  2021cites this paper
• Ion channels as convergence points in the pathology of pulmonary arterial hypertension

  2021cites this paper
• Upregulation of Calcium Homeostasis Modulators in Contractile-To-Proliferative Phenotypical Transition of Pulmonary Arterial Smooth Muscle Cells

  2021cites this paper
• NAADP‐induced intracellular calcium ion is mediated by the TPCs (two‐pore channels) in hypoxia‐induced pulmonary arterial hypertension

  2021cites this paper
• CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension

  2021cites this paper
• Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells

  2021cites this paper
• Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury

  2021cites this paper
• DDDT_A_297500 1653..1666

  2021cites this paper
• Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy

  2021cites this paper
• Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension

  2021cites this paper
• Halofuginone, a promising drug for treatment of pulmonary hypertension

  2021cites this paper
• Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

  2021cites this paper
• Response to Michiel Alexander de Raaf et al.

  2021influential citation
• Pulmonary Hypertension

  2021cites this paper
• TRPC6, a Therapeutic Target for Pulmonary Hypertension.

  2021cites this paper
• Cellular Pathways Promoting Pulmonary Vascular Remodeling by Hypoxia.

  2020cites this paper
• Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature

  2020cites this paper
• A novel rat model of pulmonary hypertension induced by mono treatment with SU5416

  2020cites this paper
• Inhibition of RELM-β prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing PLC-mediated KCNK3 decline.

  2020cites this paper
• Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.

  2020cites this paper
• Role of TG2-Mediated SERCA2 Serotonylation on Hypoxic Pulmonary Vein Remodeling

  2020cites this paper
• Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension

  2020cites this paper
• Resistin-like molecule β acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca2+-dependent PI3K/Akt/mTOR and PKC/MAPK signaling pathways

  2020cites this paper
• Magnesium Supplementation Attenuates Pulmonary Hypertension via Regulation of Magnesium Transporters.

  2020cites this paper
• Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused/ventilated mouse lung

  2020cites this paper
• Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension

  2020cites this paper
• Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension

  2020cites this paper
• PDGF/MEK/ERK Axis represses Ca2+ clearance via Decreasing the Abundance of Plasma Membrane Ca2+ Pump PMCA4 in Pulmonary Arterial Smooth Muscle Cells.

  2020cites this paper
• Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells.

  2020cites this paper
• Structural and Functional Definition of Pulmonary Vein System in Chronic Hypoxia-induced Pulmonary Hypertension Rat Model.

  2020cites this paper
• Resistin-like Molecule β Acts as a Mitogenic Factor in Hypoxic Pulmonary Hypertension via Ca2+ dependent PI3K/Akt/mTOR and PKC/MAPKs Signaling Pathway

  2020cites this paper
• Genetic knockout and pharmacologic inhibition of NCX1 attenuate hypoxia-induced pulmonary arterial hypertension.

  2020cites this paper
• Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-κB/cyclin D1 pathway

  2020cites this paper
• [Pathophysiological roles of TRPC6 channels in pulmonary arterial hypertension].

  2020cites this paper
• Platelet‐derived growth factor up‐regulates Ca2+‐sensing receptors in idiopathic pulmonary arterial hypertension

  2019cites this paper
• Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology

  2019cites this paper
• Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension

  2019cites this paper
• Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension

  2019cites this paper
• Inactivation of carboxyl terminus of Hsc70-interacting protein prevents hypoxia-induced pulmonary arterial smooth muscle cells proliferation by reducing intracellular Ca2+ concentration

  2019influential citation
• KCNK3 Channel: A New Player in the Field of Pulmonary Vascular Disease.

  2019cites this paper
• MicroRNA-mediated Downregulation of K+ Channels in Pulmonary Arterial Hypertension.

  2019cites this paper
• Multiscale modeling of ventricular–vascular dysfunction in pulmonary arterial hypertension

  2019cites this paper
• Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.

  2019cites this paper
• Clevidipine-Induced Extreme Hypoxemia in a Neurosurgical Patient: A Case Report.

  2019cites this paper
• Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro

  2018cites this paper
• A Review of Transcriptome Analysis in Pulmonary Vascular Diseases.

  2018cites this paper
• Mechanisms underlying the impact of exercise training in pulmonary arterial hypertension.

  2018cites this paper
• Two-pore channels mediated receptor-operated Ca2+ entry in pulmonary artery smooth muscle cells in response to hypoxia.

  2018cites this paper
• Transient Receptor Potential Melastatin-8 Activation Induces Relaxation of Pulmonary Artery by Inhibition of Store-Operated Calcium Entry in Normoxic and Chronic Hypoxic Pulmonary Hypertensive Rats

  2018cites this paper
• Hypoxia selectively upregulates cation channels and increases cytosolic [Ca2+] in pulmonary, but not coronary, arterial smooth muscle cells.

  2018cites this paper
• Increased CaSR and TRPC6 pulmonary vascular expression in the nitrofen-induced model of congenital diaphragmatic hernia

  2018cites this paper
• Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension

  2018cites this paper
• OBSOLETE: Pulmonary Hypertension

  2018cites this paper
• Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?

  2018cites this paper
• Type 2 inositol 1,4,5-trisphosphate receptor inhibits the progression of pulmonary arterial hypertension via calcium signaling and apoptosis

  2018influential citation
• Timothy syndrome‐like condition with syndactyly but without prolongation of the QT interval

  2018cites this paper
• Revisiting the Role of TRP, Orai, and ASIC Channels in the Pulmonary Arterial Response to Hypoxia

  2018influential citation
• Mechanobiological Feedback in Pulmonary Vascular Disease

  2018cites this paper
• Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension

  2018cites this paper
• Estudio farmacologico ex vivo/in vitro de vasos pulmonares humanos de pacientes con fibrosis pulmonar e hipertension pulmonar

  2018cites this paper
• Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension

  2018cites this paper
• ORAI Channels as Potential Therapeutic Targets in Pulmonary Hypertension.

  2018cites this paper
• Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases

  2017cites this paper